Latest Updates

The company has also received approval from the Global Fund (GF) expert review panel for its fixed dose combination, TLE 400, for…

The conclave will focus on various aspects like new separation techniques and approaches, niche topics, deeper understanding of…

Polyphor's prospects and its share price plunged this year when it halted a trial of its intravenous murepavadin antibiotic…

Former J&J executive Marianne De Backer will take the role of Head of Business Development and Licensing at Bayer’s…

The partnership aims to develop Lupin’s lead MEK inhibitor compound in combination with one of Boehringer Ingelheim’s innovative…

The global conference comprises packaging professionals searching solutions for green and ecological development of the packaging…

To be held from 7-8 November, 2019, the forum is an ideal platform to learn about the latest anti-counterfeit trends and…

The programme, rolled out last year, saw 11 Chinese cities, including Beijing and Shanghai, band together behind a tender process…

The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for…

The medicine is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS)